Steven Cohen acquired 837 Thousand Neurocrine Biosciences shares worth $119 Million. That's 0.36% of their equity portfolio (63rd largest holding). The first Neurocrine Biosciences trade was made in Q1 2015. Since then Steven Cohen bought shares sixteen more times and sold shares on fifteen occasions. The stake costed the investor $87.9 Million, netting the investor a gain of 35% so far.